Advanced search×

Mindfulness meditation alleviates depressive symptoms in women with fibromyalgia: results of a randomized clinical trial.

Sandra E SE Sephton, Paul P Salmon, Inka I Weissbecker, Christi C Ulmer, Andrea A Floyd, Katherine K Hoover, and Jamie L JL Studts

Arthritis Rheum 57(1):77-85 (2007) PMID 17266067

Depressive symptoms are common among patients with fibromyalgia, and behavioral intervention has been recommended as a major treatment component for this illness. The objective of this study was to test the effects of the Mindfulness-Based Stress Reduction (MBSR) intervention on depressive symptoms in patients with fibromyalgia.

DOI: 10.1002/art.22478
Version: za2963e q8za5 q8zb3 q8zc0 q8zd9 q8ze8 q8zf8 q8zg8
Buy PDF

Similar articles you may find interesting…

  1. A narrative review of yoga and mindfulness as complementary therapies for addiction.
    Surbhi Khanna and Jeffrey M Greeson

    Complement Ther Med 21(3):244-52 (2013) PMID 23642957

    We propose a conceptual model to inform future studies on outcomes and possible mechanisms. Additional research is also needed to better understand what types of yoga and mindfulness-based interventions work best for what types of addiction, what types of patients, and under what conditions. Overall...
    Buy PDF
  2. The relationship between depressive symptoms and erythropoietin resistance in stable hemodialysis patients with adequate iron stores.
    Baris Afsar

    Int J Artif Organs (2013) PMID 23645578

    Resistance to erythropoietin (EPO) treatment has been associated with inflammation and malnutrition in hemodialysis (HD) patients. Depression has also been associated with both inflammation and malnutrition; however, the specific relationship between depressive symptoms and EPO resistance is not kno...
    Buy PDF
  3. A multimodal imaging analysis of subcortical gray matter in fragile X premutation carriers.
    Jun Yi Wang, Randi J Hagerman, and Susan M Rivera

    Mov Disord (2013) PMID 23649693

    Approximately 40% of males with the fragile X premutation develop fragile X-associated tremor/ataxia syndrome after age 50. Although the thalamus and basal ganglia play a crucial role in movement disorders, their involvement in fragile X premutation carriers has not been systematical...
    Buy PDF